...All right. Good morning, and welcome to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm, and I want to thank everybody for joining us this week. Our first presenting company is PTC Therapeutics. And it's my pleasure to welcome CEO, Stuart Peltz, to talk to us a little bit about the company. Just a quick formatting note. There is a Q&A session after the presentation. So I'm inviting everybody, all of our viewers to -- if you'd like to submit a question, I should say, just click the blue Ask a Question icon, and I'll work those questions and where appropriate. With that, Stu, let me pass it over to you for the presentation. Stuart W. Peltz ...